Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Pediatric Oncology
How should therapy for children with gross totally resected M0 Medulloblastoma with Large Cell Anaplasia be augmented to improve outcomes?
If so, how should the chemotherapy and/or radiotherapy paradigms be adjusted to improve outcomes?
Related Questions
Do you recommend adjuvant radiotherapy for an adult patient with localized myxopapillary ependymoma, WHO Grade 2, status-post gross total resection?
What is your approach to cancer patients who inquire about alternative or complementary treatments?
How do you approach delivering ISRT to nodular lymphocyte predominant Hodgkin Lymphoma that has responded on FDG-PET/CT after chemotherapy?
How would you approach patients with primary cardiac sarcomas for adjuvant systemic treatment?
What are best practices for oncologists during the national platinum shortage?
What, if any, cardioprotective measures beyond dexrazoxane may be used to minimize cardiac risk during or after chemo- or radio-therapy?
Does the use of A+AVD versus ABVD affect your decision for consolidation RT for bulky Hodgkin lymphoma?
What are the key local therapy considerations for patients with malignant pleural effusion, bulky pleural disease, lung metastases and chest wall/diaphragm primary in a patient with Rhabdomyosarcoma or Ewing Sarcoma?
Does the use of and type of biopsy prior to therapy impact local relapse in Wilms?
How do you approach treatment of sub-total resected ZFTA fusion ependymoma after radiation therapy in a young adult?